Skip to main content

Series B Therapeutics Companies

Explore 190 therapeutics startups that raised series b funding. Access verified founder contact information and fundraising data.

Total Companies
190
Total Funding
$2.1B
Avg Funding
$84.7M
Cities
22

Export 190 Series B Therapeutics Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
London, United Kingdom
$16.3M
raised

Epsilogen is a developer of an immuno-oncology company intended to develop immunoglobulin antibodies to treat cancer.

Sep 2024
Series B

Founder Contacts

41,000+ verified contacts

Melbourne, Australia
$14.5M
raised

OccuRx is a biopharmaceutical company that focuses on the development of innovative therapeutic strategies.

Sep 2022
Series B

Founder Contacts

41,000+ verified contacts

Frederiksberg, Denmark
$47.6M
raised

Acesion Pharma is a developer of medical drugs designed for the treatment of atrial fibrillation.

Sep 2023
Series B

Founder Contacts

41,000+ verified contacts

Milan, Italy
$52.2M
raised

Genespire is a biotechnology company focused on the development of transformative gene therapies for patients affected by genetic diseases.

Sep 2024
Series B

Founder Contacts

41,000+ verified contacts

Fukuoka, Japan
$11.9M
raised

GAIA BioMedicine is a biopharmaceutical company that specializes in innovative cell therapies and immunotherapies for treating solid tumors.

Sep 2021
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 190 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Sunnyvale, United States
$23.0M
raised

Corsair Pharma is developing transformative solutions to the therapeutic profile of medications and provide superior treatment for patients.

Sep 2023
Series B

Founder Contacts

41,000+ verified contacts

Durham, United States
$5.4M
raised

Aerami Therapeutics focuses on developing novel inhaled therapies for the treatment of chronic diseases.

Sep 2022
Series B

Founder Contacts

41,000+ verified contacts

South San Francisco, United States
$43.5M
raised

Novome Biotechnologies is a biotechnology company focused on engineering defined activities into the human.

Sep 2022
Series B

Founder Contacts

41,000+ verified contacts

Southlake, United States
$25.0M
raised

Renibus Therapeutics is a clinical-stage biotech company that focuses on preventing and treating kidney disease.

Sep 2023
Series B

Founder Contacts

41,000+ verified contacts

San Francisco, United States
$115.0M
raised

Expedition Therapeutics develops treatments for COPD and other inflammatory respiratory diseases.

Aug 2026
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 190 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Newhouse, United Kingdom
$45.9M
raised

Mironid is a drug discovery company focused on therapeutics for degenerative kidney diseases, chronic inflammatory diseases, and cancer.

Aug 2026
Series B

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$153.0M
raised

Strand Therapeutics is a biopharmaceutical company applying synthetic biology to RNA therapeutics to develop single dose mRNA treatments.

Aug 2025
Series B

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$440.0M
raised

Laronde develops an eRNA-based therapeutic platform that is capable of indicating diverse proteins inside the body.

Aug 2021
Series B

Founder Contacts

41,000+ verified contacts

$38.9M
raised

etherna develops mRNA and lipid nanoparticle solutions.

Aug 2022
Series B

Founder Contacts

41,000+ verified contacts

Raleigh, United States
$105.0M
raised

Pathalys is a clinical biopharmaceutical company that develops therapeutics that improve late-stage chronic kidney disease.

Aug 2024
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 190 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Cambridge, United States
$58.0M
raised

Immunitas Therapeutics is a single cell genomics-based drug discovery company that modulates oncology targets.

Aug 2021
Series B

Founder Contacts

41,000+ verified contacts

Gaithersburg, United States
$92.7M
raised

Georgiamune is a biotechnology company developing next-generation immunotherapeutics for cancer and autoimmune diseases.

Aug 2026
Series B

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$221.0M
raised

Orna Therapeutics is a biotechnology company that specializes in fully engineered circular RNA therapeutics to treat various diseases.

Aug 2022
Series B

Founder Contacts

41,000+ verified contacts

Waltham, United States
$9.3M
raised

Regenacy Pharmaceuticals Provides Healthcare Services.

Aug 2022
Series B

Founder Contacts

41,000+ verified contacts

Basel, Switzerland
$152.0M
raised

Vaderis Therapeutics is a clinical-stage biotechnology company developing targeted therapies for rare vascular diseases.

Aug 2026
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 190 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Jersey City, United States
$118.0M
raised

Claris Biotherapeutics develops biologic therapies for corneal diseases and other disorders affecting the ocular surface.

Jul 2026
Series B

Founder Contacts

41,000+ verified contacts

San Diego, United States
$130.0M
raised

Crystalys Therapeutics is a clinical-stage biopharmaceutical company that develops targeted therapies for gout and hyperuricemia.

Jul 2026
Series B

Founder Contacts

41,000+ verified contacts

San Mateo, United States
$75.0M
raised

BigHat Biosciences is a protein therapeutics company that develops an antibody design platform guided by artificial intelligence.

Jul 2022
Series B

Founder Contacts

41,000+ verified contacts

Boston, United States
$60.3M
raised

GRO Biosciences is a biotechnology company that develops a protein therapeutics technology to improve treatments across multiple diseases.

Jul 2024
Series B

Founder Contacts

41,000+ verified contacts

Cardiff, United Kingdom
$65.0M
raised

Draig Therapeutics is a clinical-stage biopharmaceutical company that develops investigational therapies for neuropsychiatric disorders.

Jul 2026
Series B

Founder Contacts

41,000+ verified contacts

Showing 1 to 25 of 190 companies

Ready to Connect with Series B Therapeutics Startups?

Get verified founder emails, funding details, and company data for 190 series b therapeutics companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked